FSA Wealth Management LLC Takes $54,000 Position in VanEck Biotech ETF (NASDAQ:BBH)

FSA Wealth Management LLC bought a new stake in VanEck Biotech ETF (NASDAQ:BBH) during the 3rd quarter, Holdings Channel.com reports. The firm bought 303 shares of the company’s stock, valued at approximately $54,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. Truvestments Capital LLC bought a new position in shares of VanEck Biotech ETF in the 3rd quarter worth about $44,000. Mather Group LLC. bought a new stake in VanEck Biotech ETF in the second quarter worth approximately $46,000. Red Lighthouse Investment Management LLC bought a new stake in VanEck Biotech ETF in the second quarter worth approximately $51,000. Coastline Trust Co bought a new position in shares of VanEck Biotech ETF during the 3rd quarter worth approximately $59,000. Finally, Hyman Charles D acquired a new stake in shares of VanEck Biotech ETF during the 2nd quarter worth approximately $202,000. Institutional investors and hedge funds own 32.05% of the company’s stock.

VanEck Biotech ETF Trading Up 0.2 %

NASDAQ:BBH opened at $167.37 on Monday. VanEck Biotech ETF has a twelve month low of $150.62 and a twelve month high of $183.64. The company has a fifty day moving average of $171.70 and a 200-day moving average of $173.15.

VanEck Biotech ETF Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.